Millipak® Final Fill Filter
Maximize recovery and enhance protection of your high value
product
2
Intense Regulatory Focus on Final Sterile Filtration
EU GMP Annex 1 draft for the manufacture of sterile medicinal products, March 2018
PDA®
TR26 – 2008 Sterilizing filtration of liquids
 Where the claimed purpose of the filter is to sterilize, pre and post filtration integrity tests
should be performed.
 Prefiltration integrity test may be performed prior to sterilization of the filter and, preferably,
after sterilization.
 Steps should be taken to ensure that the downstream side of the system remains sterile
when performing a post sterilization, pre-use integrity test.
p 34
Benefits of Millipak® Final
Fill Filters
4 Title of Presentation | DD.MM.YYYY
Maximize
product
recovery and
cost savings
Reduced risk of
contamination
and process
errors
Comprehensive
Support
Benefits of Millipak® Final Fill
5
Easy to stabilize
Assembly setup
with handle
Stacked Disk with
Durapore®
Membrane
Flow direction
Aseptic Multi
Purpose Port
GS1 2D
barcode
Product Features
Transparent
polysulfone
housing
Product Recovery
Risk Reduction
6
Stacked Disc Design minimizes hold-up volume
Pleated Filter Stacked Disc Design Filter
.
• Upstream and downstream
support
• Particulates, oxidizables,
extractables
• Hold-up volume
• Thermal bonding
• Manufacturing concerns
• “Wasted filtration”
• Too much filter
• Not enough process
• Few materials of construction
• Low particulates
• Low oxidizables
• Low extractables
• Low hold-up means High product
recovery
• Less lost $$$
• Small filtration areas
• Maximize process efficiency
• Good for small batches
7
Proven Durapore® Membrane
oConsistent pore size and
shape
oLow protein binding
oHigh flowrate
oLow extractables
oLow particle shedding
oBroad chemical
compatibility
oExtreme robustness
Proven Durapore® membrane is the
membrane of choice for sterile filtration
of high value products.
8
Stacked Disc Design Maximizes Product Recovery with Filter Blow-
down
0 200 400 600 800 1000 1200 1400 1600 1800 2000
$0
$10,000
$20,000
$30,000
$40,000
$50,000
$60,000
Potential Revenue loss as a result of
Holdup Volume
Millipak Final Fill 200 (1000 cm^2)
0.22 Pleated Filter (900 cm^2)
Drug cost per mL
Potential
Revenue
Loss
=
Air Source;
Integrity
Tester
Blow down
9
Minimize contamination risks with Aseptic Multi-Purpose Port
(AMPP)
Risk Reduction
 Prevent contamination during pre-
use integrity testing
 Reducing contamination risk during
sampling
 Validated to maintain aseptic flow-
path during actuation
Aseptic
Actuations
Integrity
Testing
Sampling
Aseptic Multi
Purpose Port
10
AMPP- Simplify Assembly Design
Simplified Design
 Fewer Connections; less
dead volume
 Simplified operation
11
Millipak® Final Fill Filter streamlines integrity testing
Integrity
Tester
AMPP
Protects
product
flow-path
Simplified
design
reduces
product
loss
Easy
operation
reduces
errors
12
Confirming Filter Integrity
Membrane Size
20
Size
40
Size
60
Size
100
Size
200
0.1 µm
@56psi
≤ 1.5 ≤ 1.5 ≤ 1.5 ≤ 2.0 ≤ 2.0
0.22 µm
@40psi
≤ 1.5 ≤ 1.5 ≤ 1.5 ≤ 2.0 ≤ 2.0
0.45 µm
@21psi
≤ 1.5 ≤ 1.5 ≤ 1.5 ≤ 2.0 ≤ 2.0
Membrane Bubble Point
0.1 µm 70 psi
0.22 µm 50 psi
0.45 µm 26 psi
0.22 µm hydrophobic 18 psi (60/40 IPA)
17 psi (70/30 IPA)
Bubble Point
Diffusion
*must be directly connected to inlet (no tubing)
13
Materials of Construction
Capsule: PSU (polysulfone)
Disc: PSU (polysulfone)
O-ring: Silicone
AMPP: PES (polyethersulfone)
Membrane: Durapore®
PVDF
Product Offering
15
Product Offerings
*All formats available in both pre-sterilized (gamma irradiation) and non-sterile (gamma-compatible)
MOC
16
Emprove® Portfolio – available by Q1 2020
Information to start a
material qualification
• General information
• Manufacturing flow chart
• Product characterization and
qualification
• Specification, release criteria a
• Materials of construction
• Extractables summary
• Residual solvents statement
• Elem. Impurities statement
• Regulatory statements
Answers questions
during risk assessment
 Quality Self Assessment
• Supplier and CMO management
• Shelf life testing and results
• Packaging and Sterility
Validation
Supports process
optimization
 Full Extractables profile
• Elemental Impurity (ICH Q3D)
• Analytical procedure
Competitive Analysis
18 Title of Presentation | DD.MM.YYYY
Competitive Analysis
Capsules for biopharma
 Full line, 100 cm2
and up  Full line, 200 cm2
and up  Full line, 150 cm2
and up
Membrane
 PVDF(Durapore),
PES(Express)
 PVDF, PES, PES+PDVF  PES only
Holdup volume  Best in class  Standard pleated  Standard pleated
Particulates, Bioburden  Low (stacked disk)  Standard pleated  Standard pleated
Validated aseptic vent  Yes (multiple actuations)  No  No
Integrity test through vent  Yes  No  No
Process monitoring  Yes (transparent, labels)  No  No
Easy setup  Yes (stabilizer, hook, lock)  Standard  Standard
Industry-standard testing  USP 788, TOC  TOC  No
19 Title of Presentation | DD.MM.YYYY
Millipak® Final Fill Filters Offer Lowest Hold-up Volume of
Market Leading Filters
0 200 400 600 800 1000 1200 1400
0
5
10
15
20
25
30
35
40
Millipak Final Fill
Linear (Millipak Final
Fill)
Filtration area (cm2)
Hold
Up
Volume
(mL)
20
Comparison with other Millipore® Sterilizing Filters
Millipak Final Fill Millipak Opticap XL
Filtration Area 100 - 1000 100 - 1000 220 -5400
Membrane
Durapore PVDF
Stacked disk
Durapore PVDF
Stacked disk
PES, PVDF
Pore Sizes
.1μm, .22μm, .45μ
m, 5μm
.1μm, .22μm,
.45μm
.1μm, .22μm,
.45μm
Material of
construction
Polyethersulfone Polycarbonate Polypropylene
Maximum Inlet
Pressure
5.5 bar @ 60 psi 5.2 bar @ 75 psi 5.5 bar @ 80 psi
Validated Aseptic
Port   
Emprove Dossier   
Specialized
Mobius
Assemblies
  
Diffusion Testing   
Conclusion
22
 Datasheet
 User Guide
 Durapore Wetting Guide
 Product Web pages
 Product video + Wetting video
 Tech Brief holdup + blowdown
 Tech Brief AMPP performance
 Artista enablement
 Emprove MQD (0.22µm,
0.1µm)
 Emprove OED (0.22µm)
Q2 2019 TBA
 App Note SU Design and AMPP
recovery
 SURF assembly best practices and
operation video
 App Note 5um particulate removal
 Emprove MQD (5.0µm, 0.45µm)
 Emprove OED (5.0µm)
Product Resources
23
Millipak® Final Fill is the Best-in-Class, Small Scale Filter for Critical
Filtration Operations
Benefit Feature
Maximum product recovery and
cost savings
Stacked disc design minimizes product loss
Reduced risk of contamination
and processing errors
AMPP validated to prevent contamination, and
simplifies assembly design (integrity test, sample)
Comprehensive support
Emprove® suite (including E&L)
Up-to-date industry standard testing
BioReliance® Validation Services
24 Title of Presentation | DD.MM.YYYY
Holdup Volume Cost per filter
MF 20, 100cm2 1.1 140
MF 40, 200cm2 1.5 200
MF 60, 300cm2 3.2 260
MF 100, 500cm2 4.8 400
MF 200, 1000cm2 7.2 600
Sartopore2 size 4, 150cm2 3.0 69
Sartopore2 size 5, 300cm2 4.9 108
Sartopore Plat Midicap 7, 650cm2 21.2 259
SuporEKV PES Mini Kleenpak,
220cm2 6.7 67
Fluorodyne2 DFL PVDF Mini
Kleenpak, 200cm2 9.7 76
Fluorodyne2 DFL PVDF Kleenpak3,
1500cm2 32.8 292
SHC Opticap XL150, 140cm2 5.3 64
SHC Opticap XL300, 290cm2 7.7 89
SHC Opticap XL600, 590cm2 12.9 132
KVGL Opticap XL2, 900cm2 25.3 102
KVGL Opticap XL4 21.5 144
Numbers from Saving Calculator
25 Title of Presentation | DD.MM.YYYY
Aseptic Actuation
Test
parameter
Objective Treatment Result
Positive
control
Demonstrate
simulated defects
allow bacterial
ingress
O-rings removed from
device
B. diminuta
detected
Typical test
article
Demonstrate
aseptic barrier
maintained
25-40 kGy gamma
irradiation, 1x
autoclave at 121°C for
30 minutes
No
microorganisms
detected
Treated test
article
Demonstrate
aseptic barrier
maintained
25-40 kGy gamma
irradiation, 3x
autoclave at 126°C for
90 minutes, ≥18
actuations, and test
preparation autoclave
at 121°C for 30
No
microorganisms
detected
Negative
control
Demonstrate
method can be run
aseptically
≥18 actuations No
microorganisms
detected

Millipak Final Fill Filtration Presentation

  • 1.
    Millipak® Final FillFilter Maximize recovery and enhance protection of your high value product
  • 2.
    2 Intense Regulatory Focuson Final Sterile Filtration EU GMP Annex 1 draft for the manufacture of sterile medicinal products, March 2018 PDA® TR26 – 2008 Sterilizing filtration of liquids  Where the claimed purpose of the filter is to sterilize, pre and post filtration integrity tests should be performed.  Prefiltration integrity test may be performed prior to sterilization of the filter and, preferably, after sterilization.  Steps should be taken to ensure that the downstream side of the system remains sterile when performing a post sterilization, pre-use integrity test. p 34
  • 3.
    Benefits of Millipak®Final Fill Filters
  • 4.
    4 Title ofPresentation | DD.MM.YYYY Maximize product recovery and cost savings Reduced risk of contamination and process errors Comprehensive Support Benefits of Millipak® Final Fill
  • 5.
    5 Easy to stabilize Assemblysetup with handle Stacked Disk with Durapore® Membrane Flow direction Aseptic Multi Purpose Port GS1 2D barcode Product Features Transparent polysulfone housing Product Recovery Risk Reduction
  • 6.
    6 Stacked Disc Designminimizes hold-up volume Pleated Filter Stacked Disc Design Filter . • Upstream and downstream support • Particulates, oxidizables, extractables • Hold-up volume • Thermal bonding • Manufacturing concerns • “Wasted filtration” • Too much filter • Not enough process • Few materials of construction • Low particulates • Low oxidizables • Low extractables • Low hold-up means High product recovery • Less lost $$$ • Small filtration areas • Maximize process efficiency • Good for small batches
  • 7.
    7 Proven Durapore® Membrane oConsistentpore size and shape oLow protein binding oHigh flowrate oLow extractables oLow particle shedding oBroad chemical compatibility oExtreme robustness Proven Durapore® membrane is the membrane of choice for sterile filtration of high value products.
  • 8.
    8 Stacked Disc DesignMaximizes Product Recovery with Filter Blow- down 0 200 400 600 800 1000 1200 1400 1600 1800 2000 $0 $10,000 $20,000 $30,000 $40,000 $50,000 $60,000 Potential Revenue loss as a result of Holdup Volume Millipak Final Fill 200 (1000 cm^2) 0.22 Pleated Filter (900 cm^2) Drug cost per mL Potential Revenue Loss = Air Source; Integrity Tester Blow down
  • 9.
    9 Minimize contamination riskswith Aseptic Multi-Purpose Port (AMPP) Risk Reduction  Prevent contamination during pre- use integrity testing  Reducing contamination risk during sampling  Validated to maintain aseptic flow- path during actuation Aseptic Actuations Integrity Testing Sampling Aseptic Multi Purpose Port
  • 10.
    10 AMPP- Simplify AssemblyDesign Simplified Design  Fewer Connections; less dead volume  Simplified operation
  • 11.
    11 Millipak® Final FillFilter streamlines integrity testing Integrity Tester AMPP Protects product flow-path Simplified design reduces product loss Easy operation reduces errors
  • 12.
    12 Confirming Filter Integrity MembraneSize 20 Size 40 Size 60 Size 100 Size 200 0.1 µm @56psi ≤ 1.5 ≤ 1.5 ≤ 1.5 ≤ 2.0 ≤ 2.0 0.22 µm @40psi ≤ 1.5 ≤ 1.5 ≤ 1.5 ≤ 2.0 ≤ 2.0 0.45 µm @21psi ≤ 1.5 ≤ 1.5 ≤ 1.5 ≤ 2.0 ≤ 2.0 Membrane Bubble Point 0.1 µm 70 psi 0.22 µm 50 psi 0.45 µm 26 psi 0.22 µm hydrophobic 18 psi (60/40 IPA) 17 psi (70/30 IPA) Bubble Point Diffusion *must be directly connected to inlet (no tubing)
  • 13.
    13 Materials of Construction Capsule:PSU (polysulfone) Disc: PSU (polysulfone) O-ring: Silicone AMPP: PES (polyethersulfone) Membrane: Durapore® PVDF
  • 14.
  • 15.
    15 Product Offerings *All formatsavailable in both pre-sterilized (gamma irradiation) and non-sterile (gamma-compatible) MOC
  • 16.
    16 Emprove® Portfolio –available by Q1 2020 Information to start a material qualification • General information • Manufacturing flow chart • Product characterization and qualification • Specification, release criteria a • Materials of construction • Extractables summary • Residual solvents statement • Elem. Impurities statement • Regulatory statements Answers questions during risk assessment  Quality Self Assessment • Supplier and CMO management • Shelf life testing and results • Packaging and Sterility Validation Supports process optimization  Full Extractables profile • Elemental Impurity (ICH Q3D) • Analytical procedure
  • 17.
  • 18.
    18 Title ofPresentation | DD.MM.YYYY Competitive Analysis Capsules for biopharma  Full line, 100 cm2 and up  Full line, 200 cm2 and up  Full line, 150 cm2 and up Membrane  PVDF(Durapore), PES(Express)  PVDF, PES, PES+PDVF  PES only Holdup volume  Best in class  Standard pleated  Standard pleated Particulates, Bioburden  Low (stacked disk)  Standard pleated  Standard pleated Validated aseptic vent  Yes (multiple actuations)  No  No Integrity test through vent  Yes  No  No Process monitoring  Yes (transparent, labels)  No  No Easy setup  Yes (stabilizer, hook, lock)  Standard  Standard Industry-standard testing  USP 788, TOC  TOC  No
  • 19.
    19 Title ofPresentation | DD.MM.YYYY Millipak® Final Fill Filters Offer Lowest Hold-up Volume of Market Leading Filters 0 200 400 600 800 1000 1200 1400 0 5 10 15 20 25 30 35 40 Millipak Final Fill Linear (Millipak Final Fill) Filtration area (cm2) Hold Up Volume (mL)
  • 20.
    20 Comparison with otherMillipore® Sterilizing Filters Millipak Final Fill Millipak Opticap XL Filtration Area 100 - 1000 100 - 1000 220 -5400 Membrane Durapore PVDF Stacked disk Durapore PVDF Stacked disk PES, PVDF Pore Sizes .1μm, .22μm, .45μ m, 5μm .1μm, .22μm, .45μm .1μm, .22μm, .45μm Material of construction Polyethersulfone Polycarbonate Polypropylene Maximum Inlet Pressure 5.5 bar @ 60 psi 5.2 bar @ 75 psi 5.5 bar @ 80 psi Validated Aseptic Port    Emprove Dossier    Specialized Mobius Assemblies    Diffusion Testing   
  • 21.
  • 22.
    22  Datasheet  UserGuide  Durapore Wetting Guide  Product Web pages  Product video + Wetting video  Tech Brief holdup + blowdown  Tech Brief AMPP performance  Artista enablement  Emprove MQD (0.22µm, 0.1µm)  Emprove OED (0.22µm) Q2 2019 TBA  App Note SU Design and AMPP recovery  SURF assembly best practices and operation video  App Note 5um particulate removal  Emprove MQD (5.0µm, 0.45µm)  Emprove OED (5.0µm) Product Resources
  • 23.
    23 Millipak® Final Fillis the Best-in-Class, Small Scale Filter for Critical Filtration Operations Benefit Feature Maximum product recovery and cost savings Stacked disc design minimizes product loss Reduced risk of contamination and processing errors AMPP validated to prevent contamination, and simplifies assembly design (integrity test, sample) Comprehensive support Emprove® suite (including E&L) Up-to-date industry standard testing BioReliance® Validation Services
  • 24.
    24 Title ofPresentation | DD.MM.YYYY Holdup Volume Cost per filter MF 20, 100cm2 1.1 140 MF 40, 200cm2 1.5 200 MF 60, 300cm2 3.2 260 MF 100, 500cm2 4.8 400 MF 200, 1000cm2 7.2 600 Sartopore2 size 4, 150cm2 3.0 69 Sartopore2 size 5, 300cm2 4.9 108 Sartopore Plat Midicap 7, 650cm2 21.2 259 SuporEKV PES Mini Kleenpak, 220cm2 6.7 67 Fluorodyne2 DFL PVDF Mini Kleenpak, 200cm2 9.7 76 Fluorodyne2 DFL PVDF Kleenpak3, 1500cm2 32.8 292 SHC Opticap XL150, 140cm2 5.3 64 SHC Opticap XL300, 290cm2 7.7 89 SHC Opticap XL600, 590cm2 12.9 132 KVGL Opticap XL2, 900cm2 25.3 102 KVGL Opticap XL4 21.5 144 Numbers from Saving Calculator
  • 25.
    25 Title ofPresentation | DD.MM.YYYY Aseptic Actuation Test parameter Objective Treatment Result Positive control Demonstrate simulated defects allow bacterial ingress O-rings removed from device B. diminuta detected Typical test article Demonstrate aseptic barrier maintained 25-40 kGy gamma irradiation, 1x autoclave at 121°C for 30 minutes No microorganisms detected Treated test article Demonstrate aseptic barrier maintained 25-40 kGy gamma irradiation, 3x autoclave at 126°C for 90 minutes, ≥18 actuations, and test preparation autoclave at 121°C for 30 No microorganisms detected Negative control Demonstrate method can be run aseptically ≥18 actuations No microorganisms detected

Editor's Notes

  • #2 Fix Merck to M -fix
  • #10 Fix image
  • #11 Benefit of subassemblies Shrink of your assembly through main flowpath Reduce potential losses in or on tubing Fast to operate / Easier to handle Open and close amp Easier to ensure open and close
  • #15 Remove two bottom tables and put in appendix
  • #19 Add pleated to end
  • #22 Change blue to black Change from launch to availability
  • #23 First slide talk about benefit
  • #25 appendix